These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12882516)

  • 1. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription.
    Kamemura K; Hart GW
    Prog Nucleic Acid Res Mol Biol; 2003; 73():107-36. PubMed ID: 12882516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
    Vosseller K; Wells L; Lane MD; Hart GW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc.
    Wells L; Vosseller K; Hart GW
    Science; 2001 Mar; 291(5512):2376-8. PubMed ID: 11269319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of transcription factor function by O-GlcNAc modification.
    Ozcan S; Andrali SS; Cantrell JE
    Biochim Biophys Acta; 2010; 1799(5-6):353-64. PubMed ID: 20202486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional proteomics.
    Vosseller K; Wells L; Hart GW
    Biochimie; 2001 Jul; 83(7):575-81. PubMed ID: 11522385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress.
    Zachara NE; Hart GW
    Biochim Biophys Acta; 2004 Jul; 1673(1-2):13-28. PubMed ID: 15238246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
    Whelan SA; Hart GW
    Circ Res; 2003 Nov; 93(11):1047-58. PubMed ID: 14645135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylation of the c-Myc transactivation domain.
    Chou TY; Dang CV; Hart GW
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4417-21. PubMed ID: 7753821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity.
    Cheng X; Hart GW
    J Biol Chem; 2001 Mar; 276(13):10570-5. PubMed ID: 11150304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin dynamically regulates calmodulin gene expression by sequential o-glycosylation and phosphorylation of sp1 and its subcellular compartmentalization in liver cells.
    Majumdar G; Harrington A; Hungerford J; Martinez-Hernandez A; Gerling IC; Raghow R; Solomon S
    J Biol Chem; 2006 Feb; 281(6):3642-50. PubMed ID: 16332679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells.
    Dauphinee SM; Ma M; Too CK
    J Cell Biochem; 2005 Oct; 96(3):579-88. PubMed ID: 16052526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear and cytoplasmic glycosylation.
    Snow DM; Hart GW
    Int Rev Cytol; 1998; 181():43-74. PubMed ID: 9522455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar.
    Wells L; Hart GW
    FEBS Lett; 2003 Jul; 546(1):154-8. PubMed ID: 12829252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-catenin is O-GlcNAc glycosylated at Serine 23: implications for β-catenin's subcellular localization and transactivator function.
    Ha JR; Hao L; Venkateswaran G; Huang YH; Garcia E; Persad S
    Exp Cell Res; 2014 Feb; 321(2):153-66. PubMed ID: 24342833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
    Haltiwanger RS; Grove K; Philipsberg GA
    J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-linked N-acetylglucosamine and cancer: messages from the glycosylation of c-Myc.
    Chou TY; Hart GW
    Adv Exp Med Biol; 2001; 491():413-8. PubMed ID: 14533811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification.
    Vosseller K; Sakabe K; Wells L; Hart GW
    Curr Opin Chem Biol; 2002 Dec; 6(6):851-7. PubMed ID: 12470741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site mapping.
    Zachara NE; Cheung WD; Hart GW
    Methods Mol Biol; 2004; 284():175-94. PubMed ID: 15173616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational modification by O-GlcNAc: another way to change protein function.
    Kudlow JE
    J Cell Biochem; 2006 Aug; 98(5):1062-75. PubMed ID: 16598783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.